Clinical trials: Relapse to Smoking
Smoking Cessation
Smoking Cessation and Relapse Prevention in Women Postpartum
Background: Pregnancy was found to be a significant triggering factor for smoking cessation and the reduction of nicotine consumption, but 50 - 70 % of mothers who stopped smoking during pregnancy resume tobacco smoking after…
- Trial name
- EARLINT-EP3 (NCT00475046)
- Testing
- Motivational Interviewing
- Volunteers
- 2,790 people
- Sponsor
- University Medicine Greifswald
Postpartum Smoking Relapse
Transtheoretic Model, Postpartum Smoking Relapse, Smoking Cessation Intervention
The postpartum period is an important opportunity to improve maternal and fetal health by preventing smoking relapse in women. To achieve this goal, digital platforms, which are the latest technological developments are used.
- Trial name
- NCT05711225
- Testing
- smoking cessation intervention given according to the web-based transtheoretic model during pregnancy on postpartum smoking relapse.
- Where
- Turkey (Türkiye)
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Semra YILMAZ
Smoking Cessation, Coronary Artery Disease
Cytisine Compared to Combination NRT in Relapsed Smokers
Cigarette smoking causes cardiovascular disease (CVD) yet many smokers with CVD are unable to quit despite strong desire to do so.
- Trial name
- CYTvsNRT+ (NCT04286295)
- Testing
- Cytisine, Nicoderm C-Q Transdermal Product, Nicorette Lozenge Product
- Where
- Canada
- Volunteers
- 13 people
- Sponsor
- Ottawa Heart Institute Research Corporation